Evidence map›Paper›PMID 30806915›Full record

ArticleObesity surgery2019

Effectiveness of Intra-Gastric Balloon as a Bridge to Definitive Surgery in the Super Obese.

William Ball, Syed Soulat Raza, John Loy, Manel Riera, Jayaprakash Pattar, Samuel Adjepong, James Rink

Abstract read
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. A single-center experience of safety and effectiveness of adjustable intragastric balloon in patients with super obesity.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Six intragastric balloons: Which to choose?World journal of gastrointestinal endoscopy · 2021
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

William BallUniversity Hospitals North Midlands NHS Trust, Stoke-on-Trent, England. ballwilliam@doctors.org.uk.ORCID 0000-0003-0872-0363
Syed Soulat RazaUniversity Hospitals North Midlands NHS Trust, Stoke-on-Trent, England.
John LoyHomerton University Hospital NHS Foundation Trust, London, England.
Manel RieraShrewsbury and Telford Hospital NHS Trust, Shrewsbury, England.
Jayaprakash PattarShrewsbury and Telford Hospital NHS Trust, Shrewsbury, England.
Samuel AdjepongShrewsbury and Telford Hospital NHS Trust, Shrewsbury, England.
James RinkShrewsbury and Telford Hospital NHS Trust, Shrewsbury, England.
Shrewsbury and Telford Hospital NHS Trust · GBUniversity Hospitals of North Midlands NHS Trust · GBHomerton University Hospital NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBritish National guidelines (NICE) recommend bariatric surgery for patients with a body mass index (BMI) > 40 kg/m2, or BMI > 35 kg/m2 with any comorbidities of the metabolic syndrome. Intra-gastric balloons (IGB) can be used in super obese patients as a first step, before definitive surgery.

aimsQuantify weight loss 6 months after IGB placement, measure progression to definitive surgery and identify complications.

methodsData collected retrospectively on 50 patients. Forty-six proposed for definitive bariatric surgery, four patients excluded. Analysis performed using SPSS v23.0.

resultsMedian weight decreased from 165.5 to 155 kg (range 78 to 212, p < 0.01), BMI from 57.4 to 52.15 (range 32.9 to 70.5, p < 0.01), percentage excess weight loss (%EWL) was 12.9% (range - 3.3 to 64.66%, p < 0.01) and BMI reduction was 4.25 kg/m2 (range - 1.3 to 13.9, p < 0.01). Twenty-nine out of 46 patients (63%) progressed to definitive bariatric surgery. Ten out of 46 patients (21.7%) had complications requiring readmission. Seven of these patients required early balloon removal and six failed to progress to definitive surgery. Six patients had a second balloon placement, their actual weight loss was less successful, with some regaining weight. DISCUSSION: IGB is useful to aid weight loss prior to definitive bariatric surgery. Results from first balloon placement are encouraging and comparable with other studies "as reported by Genco et al. (Int J of Obes 30:129-133, 2006)." Readmission due to nausea, vomiting, dehydration and poor compliance may be associated with poor weight loss and failure to progress to definitive surgery. Second balloon placements were less successful.

conclusionIGB as bridging therapy is a safe and useful adjunct. Sequential IGBs do not seem to provide additional benefit.

Indexed as

Gastric BalloonAdultAgedBariatric SurgeryBody Mass IndexFemaleHumansMaleMiddle AgedObesity, MorbidRetrospective StudiesWeight LossYoung AdultBridge to surgeryIntra-gastric balloonSuper morbid obesity

Identifiers

PMID30806915
OpenAlexW2917905371

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.